.NET C# developer Writing about AI-assisted software development. Focused on how modern tools change productivity ...

In a preview stage, Code Review launches a team of agents that look for bugs in parallel, verify them to filter out false positives, and rank them by severity. Anthropic has introduced Code Review to ...

Anthropic launches AI agents to review developer pull requests. Internal tests tripled meaningful code review feedback. Automated reviews may catch critical bugs humans miss. Anthropic today announced ...

When it comes to coding, peer feedback is crucial for catching bugs early, maintaining consistency across a codebase, and improving overall software quality. The rise of “vibe coding” — using AI tools ...

Anthropic’s AI coding assistant, Claude Code, is getting a new feature designed to help developers identify and resolve bugs faster and more efficiently. Aptly named Code Review, the feature ...

Anthropic on Monday released Code Review, a multi-agent code review system built into Claude Code that dispatches teams of AI agents to scrutinize every pull request for bugs that human reviewers ...

PCWorld reports that Anthropic’s Claude Code AI assistant now features voice mode, allowing developers to control the coding tool through verbal commands. Currently rolling out to 5% of users with ...

Delaware residents will be facing severe weather as a blizzard passes through the First State Sunday, Feb. 22 and Monday, Feb. 23. For those who are homeless or need temporary shelter, the storm is ...

Anthropic ships major Claude Code desktop update with live app previews, automated code review, and GitHub PR monitoring with auto-fix capabilities. Anthropic released a significant update to Claude ...

Code Metal, a Boston-based startup that uses AI to write code and translate it into other programming languages, just closed a $125 million Series B funding round from new and existing investors. The ...

The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA flu vaccine candidate after holding a high-priority meeting with the company.